Comparison Of The Visian Impantable Collamer Lens with the 以视觉植入人工晶状体的比较.ppt

下载文档 降价啦

7
0
约2.55千字
约 11页
2018-06-23 发布于浙江
举报
版权申诉
保障服务

Comparison Of The Visian Impantable Collamer Lens with the 以视觉植入人工晶状体的比较.ppt

1、本文档共11页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。

Comparison Of The Visian Impantable Collamer Lens with the 以视觉植入人工晶状体的比较

Comparison of the Visian Implantable Collamer Lens with the Verisyse Phakic Intraocular Lens in High Myopia Purpose To compare outcomes of the Visian Implantable Collamer Lens with the Verisyse Phakic Intraocular Lens in patients with high myopia Methods A retrospective chart review of consecutive patients implanted with a phakic intraocular lens by one of two experienced surgeons. Results Results Results Results Average loss of endothelial cells in the first 12 months was 4.4% in the Verisyse group and 2.5% in the Visian group. Six (6) patients (8%) in the Verisyse group required enhancements with either PRK or LASIK Four (4) patients (7.1%) in the Visian group required enhancement with LASIK. Results Three eyes required enlargement of Yag peripheral iridotomies within the first post operative month in the Visian group. Four eyes developed mild peripheral anterior subcapsular opacities that were not visually significant in the Visian group. No lenses required explantation Limitations Small sample size Endothelial cell counts in the Verisyse group were measured by two different techniques, one pre-op and one post-op, resulting in higher variability in that group The inherent difference in lens position will result in different complications Conclusion Visual outcomes were similar in both intraocular lens groups. Enhancement rates for residual refractive errors were similar in both intraocular lens groups. Rate of endothelial cell loss was greater in the Verisyse, while the Visian group had more capsular opacities (visually insignificant). Conclusion The Visian ICL and the Verisyse Phakic IOL appear to be safe alternatives for the treatment of high myopia. Post market approval outcomes are helpful for physicians considering including these techniques in their practice. * * Jigna Joshi MD Marian Macsai MD Parag Majmudar MD Vanee Virasch MD A Collaboration between Northwestern and Rush University Dr. Macsai is a member of the speakers bureau for